newsfilter
← Latest News
PR Newswire·

Canntab Announces the Early Exercise of $1,259,250 Warrants

TORONTO, June 3, 2021 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to a